What's behind Hair Relaxer claims?
Chemical hair straightening and relaxer products have been the subject of growing scientific and legal scrutiny after research, including a large NIH-funded cohort study, found an association between frequent, long-term use of these products and an increased risk of uterine and other reproductive cancers.
Claims allege that manufacturers knew or should have known about the potential health risks and failed to adequately warn consumers, particularly given that these products are used more frequently among Black women.
Case criteria we screen for
Cases we source and qualify in this case type generally involve:
- A diagnosis of uterine, endometrial, or ovarian cancer
- A documented history of regular chemical hair relaxer use before diagnosis
- Medical records supporting the diagnosis
Law firm partners can share additional intake criteria at onboarding to keep referrals aligned with their practice.
How the process works
For our partners, it's straightforward:
- Law firms — tell us your capacity and any specific intake criteria; we route qualified, vetted cases in this case type to you.
- Ongoing — reporting and a dedicated contact keep volume and quality aligned.
Litigation is ongoing and consolidated in federal court, which keeps this an active case type for law firm demand.
Frequently asked questions
Is there a filing deadline for this case type?+
Yes. Statutes of limitations vary by state, which is part of why timely, accurate intake matters.
How are cases priced or valued?+
That depends on the partnership terms agreed at onboarding — reach out and we'll walk through current terms for this case type.
What compliance standards apply to this case type?+
We maintain vetted qualification criteria and intake standards for this case type to keep everything compliant with advertising and TCPA requirements.